Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study

Neurology ◽  
2011 ◽  
Vol 77 (23) ◽  
pp. 2043-2051 ◽  
Author(s):  
C. Helmer ◽  
B. Stengel ◽  
M. Metzger ◽  
M. Froissart ◽  
Z.- A. Massy ◽  
...  
Kidney360 ◽  
2021 ◽  
pp. 10.34067/KID.0005672021
Author(s):  
Anne M. Murray ◽  
Le Thi Phuong Thao ◽  
Joanne Ryan ◽  
Rory Wolfe ◽  
James B. Wetmore ◽  
...  

Background: Chronic kidney disease is a risk factor for cognitive impairment (CI),but reports of individual associations of estimated glomerular filtration rate (eGFR) and albuminuria with CI and incident dementia in healthier older longitudinal populations are lacking. Our goal was to estimate these associations in a large cohort of older healthy persons. Methods: In a longitudinal cohort study of older persons without prior cardiovascular disease, we estimated the associations between baseline eGFR (in mL/min per 1.73 m2) and albuminuria, measured as urine albumin-to-creatinine ratio (UACR, in mg/mmol) and cognitive test scores, declines in cognitive test scores and incident dementia, using adjusted linear and linear mixed models. Cox proportional hazards regression models assessed the association between baseline kidney function and incident CI no dementia (CIND) or dementia at a median of 4.7 years. Results: At baseline, among 18,131 participants, median age was 74 years, eGFR 74 (IQR 63, 84), UACR 0.8 (IQR 0.5, 1.5; (7.1 (4.4- 13.3 mg/g and 56% were female. Baseline eGFR was not associated with performance on any cognitive tests in cross-sectional analysis, nor incident CIND or dementia over median follow-up of 4.7 years. However, baseline UACR ≥ 3 (≥ 26.6 mg/g) was significantly associated with lower baseline scores and larger declines on the Modified Mini Mental State Exam, verbal memory and processing speed tests, and with incident CIND [(hazard ratio, HR, 1.19; 95% confidence interval, CI,1.07 - 1.33)] and dementia (HR 1.32;1.06 - 1.66). Conclusion: Mild albuminuria was associated with worse baseline cognitive function, cognitive decline, and increased risk for incident CIND and dementia. Screening global cognitive tests for older persons with UACR ≥ 3 mg/mmol could identify those at elevated risk of cognitive decline and dementia.


2017 ◽  
Vol 2 (2) ◽  
pp. 192-200 ◽  
Author(s):  
Manjula Kurella Tamura ◽  
Karman Tam ◽  
Eric Vittinghoff ◽  
Dominic Raj ◽  
Stephen M. Sozio ◽  
...  

Author(s):  
Saurabh Singhal

Background: In people with chronic kidney disease (CKD), cognitive decline is one of the major causes for poor outcome in terms of quality of life and survival rate. Previous studies have found an association between cardiovascular disease and psychiatric disorders in people with CKD. Physicians should keep in mind that the psychiatric changes and cognitive decline seen in all stages of CKD is to be detected early in the course of the disease, for timely management of it and for better outcome in terms of survival rate. Aim: The goal of this study is to evaluate cognitive performance in patients with chronic renal disease Material and Method: The study was conducted from March 2019 to april 2021 in department of general medicine and nephrology clinic at KDMCH, Mathura. Between March 2019 to april 2021, baseline data were obtained. The study included 108 participants (58 with CKD and 50 with ESKD). ESKD patients were ‘CKD patients with dialysis’. Various tests were used to assess brain function. Results: ESKD patients had significantly lower scores on the 3MS, TMT-A and TMT-B trials, with a difference between TMT-A and B than CKD patients. In ESKD patients, the numbers less than 3MS of speech and fluency memory, as well as visuo-position and structure, were significantly lower. ESKD patients had the highest number of patients with psychiatric disorders, as measured by the outpatient testing scores listed above 3MS, TMT-A, and TMT-B. ESKD patients had significantly higher levels of depression than CKD patients. Conclusion: Higher cognitive decline was found in the ESKD group in comparision to non-dialysis CKD group. Also ESKD was associated with higher rates of cerebro-vascular disease, cardio-vascular disease and peripheral artery disease. Keywords: Chronic Kidney Disease, ESKD, eGFR and cognitive impairment


2018 ◽  
Vol 20 (9) ◽  
pp. 1276-1284 ◽  
Author(s):  
Despina Karasavvidou ◽  
Pierre Boutouyrie ◽  
Rigas Kalaitzidis ◽  
Hakim Kettab ◽  
Kosmas Pappas ◽  
...  

2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Manjula Kurella Tamura ◽  
Eric Vittinghoff ◽  
Jingrong Yang ◽  
Alan S. Go ◽  
Stephen L. Seliger ◽  
...  

2008 ◽  
Vol 51 (4) ◽  
pp. B64
Author(s):  
Simone de Lima ◽  
Natália Fernandes ◽  
Fabiane dos Santos ◽  
Márcia Peruzzi ◽  
Marcus Bastos

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Jessica Mira Gabin ◽  
Solfrid Romundstad ◽  
Ingvild Saltvedt ◽  
Jostein Holmen

Sign in / Sign up

Export Citation Format

Share Document